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and their complex biological functions 
closely link to their high order organi-
zation; therefore such scaffolds need to 
mimic the hierarchical structure of natural 
tissues in order to provide the necessary 
structural and biomechanical framework. 
Furthermore, biomimetic scaffolds need 
to display the necessary biochemical and 
signaling cues for cellular function. The 
native ECM provides structural support 
and instructive cues to cells through the 
macromolecules found in its structure 
such as proteins, glycosaminoglycans and 
polysaccharides. ECM macromolecules 
contain bioactive signal sequences that 
are recognized by cells via cell transmem-
brane receptors called integrins. Inter-
action between integrins and bioactive 
epitopes of ECM activates signal transduc-
tion mechanisms, which can induce spe-
cifi c cellular functions including adhesion, 
migration, proliferation and differentia-
tion. Such bioactive epitopes include: the 
RGD adhesive sequence found in the structure of ECM pro-
teins such as fi bronectin and vitronectin, [ 1 ] the IKVAV peptide 
sequence from laminin known to induce neural attachment, 
migration and neurite outgrowth; [ 2 ] and the YIGSR peptide 
sequence derived from the laminin β-chain. [ 3 ] Moreover, the 
native ECM provides to cells a highly dynamic complex micro-
environment that enables cell motility and time-varying display 
of bioactive cues via continuous matrix remodeling. In natural 
cellular microenvironment, ECM is constantly degraded by 
proteases and remodeled by proteins secreted from cells. Mim-
icking the ECM can therefore be the best strategy to develop 
advanced functional materials to control cellular behavior and 
 Self-assembling proteins and peptides are increasingly gaining interest for 
potential use as scaffolds in tissue engineering applications. They self-
organize from basic building blocks under mild conditions into supramo-
lecular structures, mimicking the native extracellular matrix. Their properties 
can be easily tuned through changes at the sequence level. Moreover, they 
can be produced in suffi cient quantities with chemical synthesis or recombi-
nant technologies to allow them to address homogeneity and standardization 
issues required for applications. Here. recent advances in self-assembling 
proteins, peptides, and peptide amphiphiles that form scaffolds suitable for 
tissue engineering are reviewed. The focus is on a variety of motifs, ranging 
from minimalistic dipeptides, simplistic ultrashort aliphatic peptides, and 
peptide amphiphiles to large “recombinamer” proteins. Special emphasis is 
placed on the rational design of self-assembling motifs and biofunctionali-
zation strategies to infl uence cell behavior and modulate scaffold stability. 
Perspectives for combination of these “bottom-up” designer strategies with 
traditional “top-down” biofabrication techniques for new generations of 
tissue engineering scaffolds are highlighted. 
 1.  Introduction 
 Commonly used tissue engineering scaffolds such as collagen, 
gelatin, hyaluronic acid, chitosan, alginate, and decellularized 
extracellular matrix (ECM) are typically derived from animal or 
plant sources. As such, their poorly defi ned chemical compo-
sition impedes regulatory approval due to potential immuno-
genicity and batch-to-batch variations. There is thus a niche for 
synthetic 3D biomimetic scaffolds that are amenable to incorpo-
ration of biologically active ligands for controlling cell behavior. 
Native tissues are composed of hierarchical organization of bio-
logical structures from the nanometer to the centimeter scale 
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W to determine cell fate. Biological self-assembly offers a versatile bottom-up fabrication technology to construct such nanoscale 
materials imitating the complex hierarchical order of natural 
tissues. In particular, protein and peptide self-assembling scaf-
folds are gaining increasing interest compared to synthetic 
biodegradable polymers. [ 4,5 ] Fibrous proteins such as silks and 
elastin dominate the area of protein scaffold design. Here we 
review recent advances on genetically engineered protein 
assemblies targeted for tissue engineering applications. The 
development of advanced molecular biology strategies allows 
the recombinant production of self-assembling protein scaf-
folds in suffi cient quantities and addresses homogeneity and 
standardization issues required for applications. Furthermore, 
signaling and bioactive motifs such as cell-attachment motifs 
can be readily combined with structural framework motifs 
through genetic engineering at the sequence level. We also 
review de novo designer short peptides and peptide amphiph-
iles as scaffolds for tissue engineering. Short self-assembling 
peptides are mainly inspired from natural protein sequences 
but non-coded amino acids can also be incorporated through 
solid-state synthesis. Peptide amphiphiles are hybrid materials 
that comprise an alkyl tail and a peptidic, usually hydrophilic, 
tail. Short peptides and peptide amphiphiles that self-assemble 
into fi brillar hydrogel scaffolds are particularly interesting, in 
view of their topographical resemblance to the native extracel-
lular matrix. Peptides with less than 12 amino acids and pep-
tide amphiphiles can be easily synthesized on a commercial 
scale. During synthesis, functional motifs can be incorporated 
to modulate scaffold stability and infl uence cell fate and cell 
behavior. Such motifs can also be introduced through post-
assembly via covalent attachment to appending reactive groups 
on the peptides. Because these peptidic building blocks are 
chemically well-defi ned, regulatory approval may be expedited 
by the ability to well-characterize each batch of product. 
 2.  Genetically Engineered Protein Assemblies 
 An increasing number of genetically engineered proteins are 
based on repetitive sequences found mainly in natural fi brous 
proteins such as collagen, elastin, silkworm and spider silks. 
However, the recombinant production of suffi cient amounts 
of native, full-length proteins is challenging. As the desired 
products are typically high molecular mass proteins with repeti-
tive sequences, heterologous hosts do not express these pro-
teins very well and post-translational modifi cations, such as 
hydroxylation of prolines in collagens, also need to be resolved. 
In the last 20 years, considerable progress has been made to 
optimize protein expression in hosts such as bacteria, yeast, 
plants, or even in transgenic goats and silkworms. As this fi eld 
has been excellently reviewed elsewhere, [ 6 ] our review will focus 
on designer proteins and peptides inspired by natural fi brous 
motifs. Indeed, the repetitive sequences are used as building 
blocks for the design and expression of “recombinamer” pro-
teins, i.e., modular proteins consisting of a certain number of 
building blocks. [ 7 ] These proteins self-assemble into macromo-
lecular structures such as fi bers, fi lms, and spheres, and have 
been used in a variety of applications. We will further elabo-
rate on examples of tailor – made proteins based on natural 
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building blocks. The strategy involves the design of the desired 
building block, chemical synthesis of the corresponding DNA 
sequence, and construction of multimeric sequences through 
concatenation or recursive directional ligation. Expression and 
purifi cation of the designer constructs is then carried out at dif-
ferent scales ranging from simple laboratory setups to fermen-
tation facilities. This approach enables the designer proteins to 
maintain their self-assembling propensity in order to replicate 
the biological performance of their natural counterparts. Two 
well-studied systems are designer silk-like proteins and elastin-
like polypeptides (ELPs). More recently, inclusion bodies have 
received interest as “unconventional” protein scaffolds, though 
their applications in the fi eld of tissue engineering is less 
explored. 
 2.1.  Designer Silk Proteins 
 The term “silk” encompasses a range of fi brous materials pro-
duced by different insects for various physiological functions, 
including cocoon formation, web construction, and prey 
catching. [ 8 ] Despite the diversity of functions, silk proteins have 
similar amino acid compositions, being rich in alanine, glycine 
and serine. [ 9 ] They are high molecular mass proteins, organized 
in repetitive sequences, as exemplifi ed by the GAGAGS motif 
in silkworm silk ( Bombyx Mori ). [ 10 ] In spiders, as many as seven 
kinds of silks are produced, each fulfi lling a different func-
tion. [ 11 ] The dragline silk is used for the framework construc-
tion of the web and as a lifeline for the spider. [ 12,13 ] Dragline 
silks are composed of two main proteins, called MaSp1 and 
MaSp2 standing for major ampulate spindroins 1 and 2. [ 14 ] 
MaSp1 spindroins are composed of numerous sequence repeats 
of poly (Ala) or Gly-Ala repeats and GGX, X being most fre-
quently Ala, Tyr, Leu and Gln. MaSp2 contains poly (Ala) 
sequence repeats as well as GPGXX repeats, X being mainly 
Gly, Tyr and Gln. [ 15 ] The GPGXX motif is also the dominant 
sequence repeat of the fl agelliform silk that spirally fi lls the 
webframe and is used for capturing the insect prey. [ 16 ] Polar 
sequences that are thought to play a “spacer” role are also 
found. Poly (Ala) or poly (Gly-Ala) repeat motifs fold into tightly 
packed antiparallel beta-sheet within the assembled fi ber, as 
probed by structural methods such as Fourier transform 
infrared (FTIR), X-ray diffraction or NMR. [ 17–20 ] The GGX 
repeats are thought to adopt either 3 10 helical, or random con-
formation. [ 19,21 ] The GPGXX motif likely adopts an elastin-like, 
beta-spiral conformation similar to the elastin structural 
motif. [ 22 ] The tightly packed antiparallel beta-sheet crystallites 
confer high tensile strength, while the glycine rich motifs 
confer elasticity, [ 23,24 ] As a result, the combination of these 
structural motifs gives rise to a material that is both strong and 
elastic at the macroscopic level, [ 25 ] leading to superior material 
properties compared to synthetic, manmade fi bers. [ 26,27 ] The 
repetitive sequence motifs are fl anked by non-repetitive N- and 
C-terminal domains that are highly conserved among spe-
cies [ 28–31 ] and adopt alpha-helical secondary structure arranged 
in bundles. [ 32,33 ] These fl anking domains play an important role 
in self-assembly, as demonstrated by recent studies. [ 34–38 ] The 
biocompatibility of both silkworm silk and spider silks have 
been known since antiquity, as proven by their empirical use 
for wound healing. [ 39 ] Their importance for contemporary 
tissue engineering was heralded in a pioneering 1914 publica-
tion, where Ross Granville Harrison reported that spider web 
mesh fi laments could guide the growth of embryonic frog 
spinal neurons. [ 40 ] Over the last 30 years the majority of efforts 
for recombinant silk-like material production focused mainly 
on spider silks, in view of the availability of silkworm silk since 
silkworms are entirely domesticated. In contrast, due to the 
cannibalistic nature of spiders, they cannot be farmed. Efforts 
for expression of recombinant proteins from spider silk cDNA 
have been focused in bacteria ( E.coli ), yeast ( Pichia Pastoris ), 
mammalian cells, transgenic tobacco plants, and transgenic 
animals (for recent reviews, see ref.  [ 6b,c ] . Production in high 
yields suitable for applications is a considerable challenge for 
native-sized, high molecular mass constructs. One strategy 
which has produced encouraging results is the use of metaboli-
cally engineered  E. coli strains with elevated Glycyl-tRNA pool, 
which was used to produce modular proteins comprising 32–96 
repeats of the module [SGRGGLGGQGAGMAAAAAMG-
GAGQGGYGGLGSQGT]n. [ 41 ] Another strategy to achieve effi -
cient recombinant production was to design shorter spider silk 
proteins. For example, repetitive silk sequences were reversibly 
transcribed to DNA sequences compatible with  E.coli codon 
usage and the DNA cassettes of a single repeating motif were 
subsequently ligated using a seamless cloning technique to pro-
duce modular proteins. [ 42 ] A number of motifs can be subse-
quently combined to give an “ensemble repeat” motif, for 
example the 35 aa motif GSSAAAAAAAAASGPGGYGPEN-
QGPSGPGGYGPGGP that comprises GPGXY repeats and one 
octaalanine (A)8 stretch. This motif, named eADF4 as it is 
inspired from the dragline silk of the European garden spider 
 Araneus diadematus , was the basis for the design of recombi-
nant variants that comprise  n copies of it,  n varying from 1 to 
16. [ 33 ] Variants that are composed of 2–16 repeats self-assemble 
into fi brils upon addition of cosmotropic phosphate ions, but 
not the variant with one repeat [ 43 ] ( Figure  1 A). A detailed kinetic 
and structural characterization of the assembly process sug-
gested that the proteins convert from initially soluble forms in 
random coil conformation to insoluble, antiparallel beta-sheet 
conformation. [ 43 ] The assembly process presented a lag phase 
characteristic of nucleation and growth kinetics; the lag phase 
disappeared with the addition of seeding nuclei or already 
assembled (eADF4) C16 fi brils. The fi brils formed by this var-
iant were previously shown to adopt a cross-beta conformation 
by X-ray fi ber diffraction, Thiofl avin T and Congo Red 
binding. [ 44 ] In the cross-beta conformation, the beta-strands are 
perpendicular to the long fi bril axis and give a characteristic 
X-ray fi ber diffraction pattern with a meridional refl ection of 
4.7 Å corresponding to inter-strand spacing and a more diffuse 
equatorial refl ection around 10 Å corresponding to beta-sheet 
spacing. [ 45 ] Preformed (eADF4)C16 fi brils were also able to 
induce fi bril formation by the otherwise soluble monomer var-
iant (eADF4)C1. Overall, it was proposed that self-assembly is 
mediated by docking and hydrogen bonding formation of poly-
alanine stretches to form antiparallel cross-beta sheets. [ 43 ] Once 
this nucleus with exposed hydrophobic side chains is formed, 
further recruitment and docking of soluble monomers to the 
exposed fi bril ends is facilitated, leading to fi bril elongation. 
Covalent interconnection of the repeating motif seems to be a 
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crucial parameter for the assembly process, since at least two 
repeats are required for fi bril formation. [ 43 ] The (eADF4)C16 is 
the most studied variant that was shown to self-assemble 
fi brils [ 46 ] and also non-natural forms such as capsules, [ 47 ] 
spheres, [ 48 ] fi lms, [ 49,50 ] hydrogels, [ 51 ] and non-woven mats, [ 52 ] 
leading to potential applications in biotechnology. [ 53,54 ] The sub-
sequent introduction of a cysteine residue through genetic 
engineering allowed functionalization with enzymes, peptides 
or inorganic nanoparticles, establishing the proof-of-principle 
for a variety of applications. [ 55 ] To further enhance its function, 
specifi c cell attachment motifs were incorporated into in the 
eADF4C16 protein. The RGD motif was introduced to the 
eADF4 C16 sequence through genetic engineering, by 
appending the GRGDSPG sequence to the C-terminus [ 56 ] 
(Figure  1 B). The cyclic RGD motif c(RGDfK), f standing for 
D-phenylalanine was chemically coupled to the cysteine-con-
taining (eADF4)C16 protein via maleimide chemistry [ 56 ] 
(Figure  1 B). Both proteins were processed into fi lms that were 
found to support cell adhesion and proliferation of mouse fi bro-
blast cell line BALB/3T3 compared to the non-RGD containing 
proteins, or compared to the negative control sequence RGE [ 56 ] 
(Figure  1 C). In terms of in vivo applications, fi lms of the 
(eADF4)C16 protein were tested as coatings of silicone breast 
implants. In the absence of a coating, the hydrophobic surface 
of these silicone implants favors nonspecifi c attachment of 
serum proteins, which causes infl ammation and induces tissue 
formation, leading to periprosthetic capsular fi brosis. Silk pro-
tein fi lm coatings present a more acceptable surface to the body 
and were found to signifi cantly reduce capsule thickness and 
post-operative infl ammation. [ 57 ] Recently, the (eADF4) C16 pro-
tein passed a number of preclinical safety tests to evaluate tox-
icity and immune reactions, and is now commercially available 
from AM silk. Applications other than implant coatings 
(BioShield-S1), include wound care dressings (SanaSilk) and 
skin care products. 
 Miniature dragline spider silk proteins that carry four poly-
Alanine/Glycine- rich repeats and the non-repetitive C-ter-
minal domain, called 4RepCT were also recombinantly pro-
duced ( Figure  2 A). The purifi ed protein self-assembles into 
macroscopic fi bers in physiological buffer [ 58 ] (Figure  2 B). The 
fi bers can be processed into mesh, fi lms and foams that sup-
port attachment, growth, and collagen type I secretion of fi bro-
blasts. [ 59 ] Moreover, cell attachment motifs can be genetically 
incorporated and do not affect the self-assembling propensity 
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 Figure 1.  A) Modular structure of natural and recombinant spider proteins. The natural dragline silk of the European garden spider comprises at 
least two major proteins, ADF3 and ADF4, both consisting of a repetitive core (red) and N-and C-terminal nonrepetitive domains (green and yellow). 
The repetitive consensus motif of the core (C-module) was the basis for the design and optimized expression of variants with  n numbers of modules 
termed (eADF4) (Cn). Reproduced with permission. [ 43 ] Copyright 2014, Elsevier. B) Functionalization strategies of the (eADF4)C16 variant with RGD 
motifs. For the chemical modifi cation, the cyclic RGD motif c(RGDfK), f standing for  D -phenylalanine was chemically coupled to the cysteine-containing 
(eADF4)C16 (ntag Cys ) protein via maleimide chemistry. The genetically modifi ed variant C16spRGD, was generated by hybridizing the RGD motif and 
a spacer sequence with (eADF4)C16. C) Adhesion of BALB/3T3 mouse fi broblasts to, C16spRGD (genetically engineered) variant fi lms, and (ntag Cys )
C16 c(RGDfK), (chemically modifi ed) variant fi lms, as compared to the corresponding RGE variant fi lms and (eADF4)C16 fi lms. Adhesion was also 
measured for non-treated (NTCP) and treated (TCP) cell culture plates and fi bronectin-coated cell culture plates (FCCP). Adhesion was normalized to 
the value for treated (TCP) cell culture plates that was set as 100%. A signifi cantly higher cell adhesion was observed for the C16spRGD (genetically 
engineered) variant fi lms. Panels (B,C) reproduced with permission. [ 56 ] Copyright 2012, Elsevier.




of the 4RepCT protein, while remaining exposed following 
self-assembly. The RGD peptide from fi bronectin and the non-
functional control RGE were incorporated at the N-terminus 
of the protein. [ 60 ] Other cell-binding motifs used were the pep-
tide YIGSR and the IKVAV peptide from laminin (Figure  2 B). 
Four different cell types (fi broblasts, keratinocytes, endothelial 
and Schwann cells) showed signifi cantly improved adherence 
to the RGD-containing matrices [ 60 ] (Figure  2 C). The Schwann 
cells also adhered to the IKVAV-containing matrices, while no 
signifi cant effect was detected in YIGSR-containing matrices. 
Materials based on the 4RepCT protein are commercialized as 
Spiber biomaterials. Apart from short peptide motifs, longer 
peptide sequences or entire biologically active domains can also 
be fused to genetically engineered proteins inspired from spider 
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 Figure 2.  A) Sequence and schematic representation of the 4RepCT protein. Poly-alanine segments are shown in bold (symbolized with the black boxes 
marked with “A”) and serine/glycine-rich segments in bold italics (symbolized with lines marked “G”). The non-repetitive C-terminal domain sequence 
is shown in italics and is symbolized with the back oval shape. The grey box marked with “SA” corresponds to a stretch that is rich in serines/alanines. 
Reproduced with permission. [ 59 ] Copyright 2010, Elsevier. B) Schematic representation of functionalized 4RepCT proteins. WT stands for the 4RepCT 
protein, NRC for the 4RepCT protein with the N-terminal domain, and RGD, RGE, IKVAV, and YIGSR stand for the 4RepCT protein with the respective 
functional sequences. Photographs of different forms of matrices for WT (left) and the RGD variant (right) are as follows (from top to bottom): fi bers, 
foams and fi lms. The scale bar is 1 cm. C) Live and dead stained fi broblasts cultured for 24 h on fi lms of functionalized 4RepCT proteins. FN stands 
for fi bronectin fi lms. Reproduced with permission. [ 60 ] Copyright 2013, Elsevier.




W silks, generating multifunctional proteins. Block copolymers were designed comprising a basic building block, AB, A being 
a hydrophobic alanine and glycine block GAGAAAAAGGAG 
and B being a hydrophilic block that contains four GGX repeats 
separated by the GSQGSR sequence. 6–15 mers of the AB 
basic building block were recombinantly expressed in bacteria 
and subsequently adopted various morphologies, ranging from 
fi brils to micelles in aqueous or alcohol solvents. [ 61 ] Fusions of 
these protein blocks with silica-nucleating peptides such as the 
KSLSRHDHIHHH or with the R5 peptide from the silaffi n pro-
tein from diatoms (SSKKSGSYSGSKGSKRRIL) were generated 
and found to act as scaffolds for silica templating. [ 62,63 ] Fusion 
proteins of the hexamer with bone sialoprotein were found to 
conserve the self-assembling ability of the silk domain while 
incorporating the functionality of the bone sialoprotein. [ 64 ] 
Films made from the fusion protein directed the proliferation 
and osteogenic differentiation of human mesenchymal stem 
cells in osteogenic medium. [ 64 ] The functional domain can be 
replaced with antimicrobial peptides such as human defensins 
and hepcidin, giving rise to fusion proteins with microbicidal 
activity that concurrently supported the growth of mammalian 
cells. These new developments open new avenues in the design 
of anti-infection biomaterials. [ 65 ] 
 2.2.  Elastin-Like Polypeptides (ELPs) 
 Elastin is a structural protein of the extracellular matrix that 
confers elasticity to tissues such as aorta, lungs and skin. Insol-
uble elastin fi bers assemble following the proteolytic cleavage 
of its soluble precursor, tropoelastin. [ 66 ] The primary sequence 
of elastin is characterized by the pentapeptide repeats VPGXG, 
X being any amino acid except proline. The proline and glycine 
residues are essential for the adoption of a fl exible beta-turn 
structure as the main secondary structure of elastin. [ 67 ] The 
molecules of elastin have high extensibility, and resume their 
original shape after stress release with low hysteresis, or high 
resilience. [ 68 ] ELPs, for “elastin-like polypeptides” are macro-
molecules based on these repeating units that can be designed 
in a controlled number and recombinantly expressed. [ 7 ] The 
term “recombinamers” was coined to convey their dual nature, 
as recombinant proteins and poly-mers. [ 69 ] Concatamers of the 
basic structural motif can be designed and expressed using a 
process of “recursive directional ligation” (RDL). RDL is based 
on the design of a DNA monomer with complementary sticky 
ends and the creation of concatamers through repeated cycles 
of digestion and ligation. [ 70 ] These recombinant proteins mimic 
the structural properties of natural elastin, particularly the pro-
pensity for self-assembly. They are able to undergo reversible 
thermal transition above a certain critical temperature in a pro-
cess called inverse temperature transition or coacervation. [ 7 ] 
Below this transition temperature called (Tt), the elastin chains 
are thought to be essentially in random conformation and sur-
rounded by water clathrates. Above this temperature, the chains 
fold into a “beta-spiral” conformation and assemble mainly 
through intrachain and interchain hydrophobic interactions, 
forming a separate phase. The transition temperature depends 
on conditions such as pH, ionic strength, but also on amino 
acid composition. Thus, ELPs can be rationally designed to 
produce responsive materials with controlled properties. [ 71 ] An 
enormous amount of literature exists for the ELPs and their 
applications in tissue engineering that has been extensively 
reviewed previously. [ 4,72,73 ] For the purposes of this article we 
focus on the increasing number of recent studies of designer 
ELPs targeted for tissue engineering. Charged amino acids can 
be introduced at the position X, for example when a glutamate 
is introduced at this position at acid pH where its carboxyl side 
chains are protonated, the ELP [(VPGVG) 2 -(VPGEG)-
(VPGVG)] 15 forms fl at polymer sheets on surfaces. [ 74 ] At neutral 
pH where the carboxyl side chains are deprotonated, the nega-
tively charged glutamates along with their hydrating water mol-
ecules get segregated from the rest of the hydrophobic polymer; 
as a result, nanopores form in the fi lm. [ 74 ] In solution, this pH 
dependence infl uences also the transition temperature. A 
number of [(VPGVG) 2 -(VPGEG)-(VPGVG) 2 ] n ELPs were 
designed, n being equal to 5, 9, 15, 30, and 45 in order to study 
the this pH dependence. For example, for the [(VPGVG) 2 -
(VPGEG)-(VPGVG) 2 ] 45 , at PH 2.5, the transition temperature is 
28 °C, while at pH 8 shifts to 85 °C, an enormous shift given 
that the glutamates represent 4% of the recombinamer chain 
residues. [ 71 ] Lysine can be introduced at position X, to enable 
crosslinking and conjugation chemistries. Moreover, multifunc-
tional ELPs can be designed that comprise cell attachment 
motifs or protease digestion sites. Such an example is illus-
trated by the design of the recombinamer [(VPGIG) 2 -(VPGKG)-
(VPGIG) 2 -(EEIQIGHIPREDVDYHLPY)-(VPGIG) 2 -(VPGKG)-
(VPGIG) 2 -(VGVAPG) 3 ] n where  n = 10. [ 75 ] The (VPGIG) module 
confers the material properties and stimuli-responsive nature, 
while the VPGKG module can be used for crosslinking chem-
istry. The EEIQIGHIPREDVDYHLPY sequence contains the 
REDV motif from the CS5 fi bronectin domain which is specifi c 
for endothelial cell recognition. The VGVAPG sequence allows 
recognition by elastase in order to mimic the physiological 
pathways of elastin digestion during ECM remodeling. Subse-
quent designs incorporated the entire RGD–containing 
sequence from fi bronectin, AVTGRGDSPASS, on (VPGIG) and 
(VPGKG)-based ELPs ( Figure  3 A). The RGD-containing ELP 
was used to coat polylactic acid (PLA) surfaces, via physisorp-
tion or chemical attachment. The functionalized surfaces with 
the RGD-containing ELP were found to enhance attachment 
and proliferation of rat mesenchymal stromal cells (rMSCs) 
compared to surfaces functionalized with the control ELP. [ 76 ] 
This recombinamer was immobilized on titanium surfaces, 
again through physisorption or covalent attachment, leading to 
adhesion and proliferation of hMSCs. Of note, nonspecifi c pro-
tein attachment was signifi cantly lower in the coated surfaces 
compared to the bare metal surface, and the surfaces with cova-
lently attached ELPs showed higher stability than the ones with 
physisorbed ELPs, suggesting their suitability to improve 
implant biocompatibility. [ 77 ] ELPs targeted for calcium deposi-
tion, were designed by incorporating the 15aa sequence 
DDDEEKFLRRIGRFG from the human salivary peptide 
statherin (which has high affi nity for hydroxyapatite) with the 
basic building blocks VPGIG and VPGKG [ 78 ] (Figure  3 A). These 
ELPs were covalently attached through the lysine residue to tita-
nium surfaces that were previously etched with alkali and 
silanized. The functionalized surfaces were able to nucleate 
deposition of amorphous calcium phosphates and these 
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 Figure 3.  A) Sequence of designer elastin-like recombinamers with incorporated bioactive motifs. The basic elastin-like building blocks VPGIG 
and VPGKG are represented in yellow and blue letters, respectively. The bioactive sequences are represented in red letters. The 15aa sequence 
DDDEEKFLRRIGRFG from the human salivary peptide statherin confers high affi nity for hydroxyapatite and the RGDS and REDV motifs target cell 
attachment. B) Osteoblastic differentiation measured by the expression of transcription factor osterix in the nuclei of rat mesenchymal stem cells. 
a) Percentage of cells expressing osterix. FN stands for fi bronectin (FN in osteogenic media is the positive control). In (b–e) confocal images 
of nuclei expressing osterix (pink) and non-expressing (blue) are shown for smooth membranes fabricated by the HAP recombinamer (b), HAP 
membrane patterned with channels (c), fi bronectin-coated glass (d), and smooth PDMS surface (e). Reproduced with permission. [ 79 ] Copyright 
2014, Elsevier.





mineralized surfaces further supported and enhanced attach-
ment and differentiation of a preosteoblast cell line. [ 78 ] Cell 
attachment motifs such as RGDS or REDV were combined 
with the aforementioned calcium mineralizing sequences 
within the same ELR in order to test any synergistic effects 
towards bone regeneration applications. Membranes formed 
from such ELRs were recently tested, in combination with dif-
ferent topographies (smooth, channels, holes and posts), for 
their effect on rat mesenchymal stem cell fates [ 79 ] (Figure  3 C). 
ELR membranes containing only statherin sequences signifi -
cantly enhanced osteogenic differentiation in non-osteogenic 
media on all topographies. Enhancement, although to a lesser 
extent was observed for the bifunctional statherin – RGDS 
membranes compared to fi bronectin-coated controls in osteo-
genic media. [ 79 ] These membranes were recently tested in a 
rodent bone defect model and encouraging bone formation was 
observed following implantation. [ 80 ] The modular design of 
elastin – mimetic ELPs offers the possibility of tuning indepen-
dently the display of bioactive motifs, the mechanical properties 
(by varying the density of crosslinking), and the degradation 
and remodeling rates of the designer scaffolds (by introducing 
protease cleavage motifs). Such designs are exemplifi ed in the 
work of Heilshorn at al. where basic elastin motifs containing 
lysine residues were interspersed either with sequences con-
taining the RGD motif or sequences sensitive to cleavage by 
urokinase plasminogen activator (uPA). [ 81 ] The urokinase plas-
minogen activator is locally secreted by tips of growing neurons 
and was introduced to enable remodeling of the scaffold in 
post-implantation conditions. Hydrogels formed from con-
structs with RGD motifs were studied in vitro as scaffolds for 
the model PC12 neuronal-like cell line and were shown to sup-
port adhesion and neurite outgrowth. When constructs com-
prising RGD motifs were mixed in 1:1 ratio with three different 
constructs comprising uPA sites, or with the construct com-
prising the scrambled RDG motif, similar adhesivity was 
observed, indicating that degradation sites did not interfere 
with cell adhesion. [ 81 ] Hydrogels with tunable mechanical prop-
erties and display of RGD sites could also be molded and 
studied in a three-dimensional context using silicone molds 
inserted in cell culture plates [ 82 ] ( Figure  4 ). The mechanical 
properties of the hydrogels could be tuned by varying the ratio 
of crosslinking reagent to the primary amine content, without 
affecting the display of available RGD sites ( Figure  5 A). Alter-
natively, the density of available RGD sites per volume unit 
could be tuned without affecting the mechanical properties of 
the hydrogel by homogenously mixing ELPs with and without 
the RGD motif (Figure  5 B). The hydrogels could support the 
attachment of DRG neurons, and viability after 1 day was not 
affected by the variations in RGD density or crosslinking den-
sity (Figure  5 C,D). The sole presence of RGD ligands resulted 
in clear increase in length and number of extending neurites by 
day 3 of culture. In the range of 0.5 to 2 kPa moduli, the most 
compliant hydrogels supported statistically better neurite out-
growth, with neurites extending by day 1 in 0.5 kPa hydrogels, 
by day 3 in 1.5 kPa hydrogels, and only by day 7 in 2.1 kPa 
hydrogels. Moreover, these materials could be molded into 
hollow tubes, pointing to their eventual applicability as nerve 
guiding materials for in vivo applications. [ 82 ] 
 One of the big advantages of ELPs that carry bioactive 
motifs such as RGD is their amenability to thin fi lm fabrica-
tion, or even multilayer fi lm fabrication by LBL (layer-by-layer) 
procedures. The fi rst thin fi lms of and ELP containing the 
RGD motif were fabricated using as a substrate chitosan, a bio-
compatible and bacteriostatic anionic polysaccharide of marine 
origin. The chitosan-ELP interaction is presumably driven by 
electrostatic interactions between negatively charged aspartates 
above their pKa and the anionic groups of chitosan. The tem-
perature responsiveness of ELP deposited on chitosan confer 
“smart” behavior to the chitosan substrate. Contact angle 
measurements showed that the ELP coated-surfaces turn more 
hydrophilic from 25 °C to 50 °C. This was presumably due to 
the segregation of the hydrophobic parts of the polymer (con-
fi rmed by the appearance of nanometer-sized spherical struc-
tures, as can be seen using atomic force microscopy (AFM)) 
with concomitant exposure of the hydrophilic RGD moieties. 
At 37 °C, where the surface of these fi lms is moderately hydro-
phobic, the fi lms could support improved adhesion and pro-
liferation of the osteoblast-like osteosarcoma cell-line SaOs-2 
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 Figure 4.  A) Schematic representation of modular elastin-like poly-
peptides with bioactive motifs. The basic elastin-like motifs are repre-
sented with a green box and the bioactive motif sequences as a grey 
diamond. B) The elastin-like domains contain lysines (purple) that can 
be crosslinked with amine crosslinking reagents to form a 3D network. 
C) Photograph (left) and schematic representation (right) of a semi-
transparent ELP hydrogel casted in a silicone mold (red) within a 24-well 
plate, designed to encapsulate DRG cells. Reproduced with permission. 
 [ 82 ] Copyright 2013, Elsevier.




compared to bare chitosan fi lms. [ 83 ] This has provided the pos-
sibility for multilayer alternating fi lms of ELPs and chitosan, 
that display sharp and reversible response not only to tempera-
ture, but also to pH and ionic strength; the same hydrophilic 
transition that was observed at 50 °C was also observed for 
pH 11 and 1.25  M ionic strength. Again, improved adhesion 
and proliferation of the SaOs-2 cell line was observed when the 
last layer was an ELP-RGD layer compared to a chitosan layer, 
or to an ELP layer with a scrambled RDG sequence. [ 84 ] The 
LBL strategy can elegantly be transferred from two to three 
dimensions; microcapsules of alternating ELP and chitosan 
layers can be fabricated by sequential adsorption using cal-
cium carbonate spheres as sacrifi cial templates. These thermo-
responsive microcapsules are non-cytotoxic and could be used 
as biocompatible vehicles for local injection at tissues com-
bined with delivery of small molecule therapeutics, or even 
bigger molecules such as growth factors. [ 85 ] Moreover, they can 
be internalized by hMSCs and progressively degraded inside 
the cells, further suggesting their eventual use in intracellular 
drug delivery applications. [ 86 ] 
 ELPs that combine elastin building blocks with silk 
building blocks are also the subject of intense investigation, 
since they combine the elasticity and resilience of elastin with 
the tensile strength of silk sequences. Depending of the rela-
tive ratio of the two building blocks, they either form gels in 
physiological temperatures, [ 87 ] or solutions that can be elec-
trospun into fi brous mats that support cell attachment and 
proliferation. [ 88 ] 
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 Figure 5.  A) Elastic moduli of crosslinked hydrogels can increase with increasing the ratio of crosslinking reagent (THCP) to lysines contained in 
the ELP without affecting the display of RGD ligands. B) Alternatively, the density of RGD ligands can be tuned without altering the gel mechanical 
properties, as refl ected by the mass swelling ratio. C) Live/ dead essay in DRG cell culture explants after one day of culture. D) Cell viability after 1 day 
of culture is not affected by the RGD ligand density or the hydrogel crosslinking density. Reproduced with permission. [ 82 ] Copyright 2013, Elsevier.





 2.3.  Inclusion Bodies (IBs) Formed from Recombinant Proteins 
 Another class of self-assembling protein materials that are 
recently emerging as promising biocompatible materials are 
inclusion bodies (IBs). Inclusion bodies are pseudospherical 
particles of aggregated polypeptide chains and are frequently 
formed during overexpression of heterologous proteins in 
 E. coli. They are refractile with dimensions ranging from 50 to 
500 nm and can be distinguished under phase contrast micro-
scopy; in transmission electron microscopy, they appear as 
electron-dense deposits. [ 89 ] They mainly contain the expressed 
protein and sediment at low centrifugation speeds following 
cell lysis, therefore can be non-chromatographically purifi ed 
by repeated cycles of centrifugation. Recent structural studies 
with hydrogen/deuterium exchange coupled with NMR and 
solid-state NMR suggested that inclusion bodies contain seg-
ments of the polypeptide chain engaged in amyloid-like fi brils 
in cross-beta conformation. [ 90 ] A signifi cant fraction of the 
chains seem to be properly folded, especially when enzymes or 
fl uorescent proteins are expressed as fusion proteins with short 
aggregation-inducing peptide tags. [ 91 ] Inclusion bodies behave 
as particulate, hydrated and porous nanomaterials that exhibit 
nanoscale topographical features similar to the ones presented 
by the natural ECM. [ 92 ] When patterned on amino-terminated 
silicon surfaces, they support cell attachment and prolifera-
tion. [ 93 ] Moreover, IBs patterned in different densities using 
microcontact printing promote preferential attachment and 
alignment of fi broblasts along the specifi c pattern. This paves 
the way for applications in 2D microscale surface engineering. 
The advantage of IBs is that their size, morphology, stiffness, 
and other physical properties can be tuned by careful selection 
of the bacterial production strains and culture conditions. [ 94 ] 
For example, the usual shape of IBs is spherical or ovoid, pre-
sumably due to the balance of deposition and degradation pro-
cesses of polypeptide chains at their surface. Different genetic 
backgrounds relevant to the protein quality control factors 
(such as chaperones and degrading proteases) could infl uence 
size, shape and topography of produced IBs, all of them being 
factors sensed by attaching cells. For example, strains defi -
cient in the ClpP protease produce unusual tear-shaped IBS 
that slightly promote proliferation of new born hamster kidney 
(BHK21) cells compared to polystyrene control surfaces, while 
they promote proliferation of rat pheochromocytoma (PC12) 
cells much more effi ciently ( Figure  6 ). 
 Inclusion bodies are well-tolerated by mice after oral delivery 
in high doses, with the animals showing no weight loss, 
normal food intake and no signs of discomfort. No histological 
intestinal damage was also detected. [ 95 ] This recent body of evi-
dence suggest their potential use as biocompatible materials, [ 96 ] 
although still their safety has to be fully assessed. 
 3.  Short Peptides that Self-Assemble Into 
Biomimetic Hydrogel Scaffolds 
 Self-assembling peptide scaffolds have a long history of being 
applied as in vitro cell culture substrates, implantable scaffolds, 
regenerative therapies and matrices for the delivery of encap-
sulated or conjugated bioactive therapeutics. [ 97 ] The biomimetic 
microarchitecture of short peptide hydrogel scaffolds promotes 
cell proliferation and migration even in the absence of bioactive 
motifs for cell signaling and attachment. Thus, the innate self-
assembling property can be exploited to promote the delivery 
of cells and therapeutics, suggesting applications as minimally 
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 Figure 6.  Geometries of inclusion bodies produced in various genetic backgrounds and their infl uence on cell growth. A) Confocal images of tear-
shaped inclusion bodies formed by a fl uorescent protein (mGFP) produced in an  E. coli strain defi cient in the ClpP protease. B) Scanning electron 
microscope (SEM) images of inclusion bodies produced in the WT background, a strain defi cient in the DnaK chaperone, and the strain defi cient in 
the ClpP protease. C) Growth of two different mammalian cell lines, as measured by the MTT assay, on DnaK defi cient and ClpP strains, compared to 
polystyrene surfaces without IBs. Reproduced with permission. [ 94 ] Copyright 2010, IOP Publishing.




invasive injectable therapies. Considering that supramolecular 
self-assembly is reversible because it is predominantly held by 
weak non-covalent interactions, many short peptide hydrogels 
are capable of dynamic reassembly following mechanical per-
turbations and are thus self-healing. [ 98 ] 
 Another major advantage of using peptides is their inherent 
biocompatibility and biodegradability as many self-assembling 
peptides are inspired by motifs found in nature. Chemical syn-
thesis also permits the inclusion of non-coded and synthetic 
amino acids, peptidomimetics and synthetic functional groups. 
This has signifi cantly broadened the scope of peptidic building 
blocks, which has in turn led to greater understanding of the 
intrinsic nature of self-assembly and the extrinsic factors which 
modulate the physiochemical properties of the resulting scaf-
fold. The combinatorial display of different bioactive motifs and 
enzymatic degradation sites, as well as incorporation of soluble 
factors, is integral to designing scaffolds that recapitulate the 
complex ECM microenvironment. The nanofi brillar topography 
and porous microarchitecture, combined with biomolecules 
encapsulated in the hydrogel environment provides a multitude 
of approaches for enhancing cell proliferation and differentia-
tion in regenerative medicine. 
 There are several different classes of short peptides that form 
nanofi brous hydrogels, as defi ned by the secondary structure of 
the motif that drives self-assembly. Most notably, early work on 
self-assembling peptides was inspired by β-sheet and α-helical 
sequences found in naturally occurring proteins. Since then, 
insights into peptide folding and the intermolecular interac-
tions that drive self-assembly have led to the emergence of 
rationally designed de novo motifs. For a subset of these syn-
thetic motifs, non-natural amino acids and functional groups 
have been incorporated to drive self-assembly via building 
blocks that cannot be replicated by nature. 
 3.1.  Short Peptides with β-Sheet Secondary Structure 
 The β-sheet motif is characterized by periodic repeats of hydro-
philic and hydrophobic amino acids, which subsequently stack 
via intermolecular hydrophobic interactions between the inter-
molecular hydrophobic interfaces and electrostatic interactions 
between the intermolecular hydrophilic interfaces to form 
nanofi bers. Due to the strong intermolecular interactions that 
drive β-sheet self-assembly, the resulting hydrogels are very 
stable, which bodes well for long term in vitro cultures and 
in vivo implants for tissue regeneration. The stability of the 
β-sheet secondary structure also facilitates the incorporation of 
biochemical cues for modifying cell behavior; β-sheet peptide 
hydrogels are often modular scaffolds consisting of biofunc-
tional motifs appended to the self-assembling domain. 
 The typical β-sheet motif is exemplifi ed by the self-comple-
mentary RADA16 peptide. [ 99 ] In an aqueous media, the hydro-
phobic alanines form overlapping hydrophobic interactions, 
while the positive arginine and negative aspartic acid residues 
of adjacent peptides pack together through intermolecular ionic 
interactions in a checkerboard-like manner. Consequently, the 
β-sheets stack to form 10nm nanofi bers, which in turn aggre-
gate to form hydrogel scaffolds. These scaffolds are capable of 
self-healing: when sonication is repeatedly applied to disrupt 
the intermolecular interactions and force the collapse of the 
hydrogel into the liquid state, the peptide constituents gradually 
reassemble into nanofi bers that were indistinguishable from 
those in the original hydrogel. The mechanical stiffness of the 
reassembled hydrogel is also uncompromised. [ 100 ] The propen-
sity for dynamic self-assembly into nanofi bers is retained by 
D-chiral isoform peptides, which has the additional advantage of 
being resistant to enzymatic degradation. [ 101 ] RADA16 hydrogel 
scaffolds promote cell growth, proliferation and migration [ 102 ] 
and have been used in a wide range of biomaterial applications, 
including hemostasis, [ 101a  ,  103 ] cartilage [ 104 ] and bone [ 105 ] repair, 
intervertebral disc therapy, [ 106 ] hepatocyte differentiation, [ 107 ] 
neuronal regeneration, [ 108 ] cardiac tissue regeneration, [ 109 ] and 
connective tissue repair. [ 110 ] To promote specifi c cell-scaffold 
interactions, biologically active motifs for cell-adhesion and dif-
ferentiation can be chemically conjugated prior to self-assembly 
( Figure  7 ). Such modifi cations do not compromise the mechan-
ical integrity of the bulk structure and the appended motifs can 
be displayed in a specifi c manner so as to optimize their biolog-
ical activity. [ 110,111 ] For instance, osteogenic motifs ALKRQGRT-
LYGF (osteogenic growth) and DGRGDSVAYG (osteopontin 
cell adhesion) appended to the C-terminus of RADA16 pro-
moted mouse pre-osteoblast MC3T3-E1 cell proliferation and 
osteogenic differentiation. [ 111b ] These different functional 
motifs can be incorporated in the same scaffold by simply 
mixing them at various ratios. The resulting modifi ed designer 
scaffolds can also be used to encapsulate soluble biomolecules. 
The facile encapsulation of drugs and growth factors enables 
the slow, controlled release of these biomolecules to adjacent 
cells. [ 112 ] To date, RADA16 has been used to deliver epidermal 
growth factor to accelerate cutaneous wound healing, platelet-
derived growth factor, stromal cell-derived factor-1 and insulin-
like growth factor to the post-infarction myocardium. [ 109,113 ] In 
view of its excellent biocompatibility, RADA16 has since been 
successfully licensed and is commercially available as PuraMa-
trix for laboratory and pre-clinical applications. Its clinical appli-
cation as a surgical hemostatic agent has received the CE mark 
under the trade name PuraStat, for which it is currently under-
going post-market surveillance in the European Union and 
will be subject to investigational studies for US Food and Drug 
Administration (FDA) approval. PuraMatrix is also currently 
undergoing clinical trials as a dental bone regenerative therapy 
as a bone void fi ller to be inserted into bony voids to resorb and 
be replaced with bone for dental implants. 
 Using aromatic residues as the hydrophobic component of 
the β-sheet motif, a class of glutamate-rich peptides exempli-
fi ed by Ac-QQKFQFQFEQQ-NH 2 (Q11) self-assemble in an 
anti-parallel fashion to form nanofi brils. Modifying the pep-
tides to incorporate a C-terminal thioester enables cross-linking 
via native chemical ligation with an N-terminal cysteine. [ 114 ] 
The cross-linked hydrogels are signifi cantly stiffer while main-
taining the nanofi brillar morphology of the parent hydrogels; 
resulting in enhanced endothelial cell proliferation. Similar 
to RADA16, functionalization with cell signaling motifs does 
not compromise Q11 self-assembly. Q11 bearing cell adhesion 
ligands RGDS, IKVAV, and YIGSR form multicomponent coas-
sembling hydrogels that enhanced endothelial cell attachment, 
spreading and proliferation [ 115 ] ( Figure  8 ). β-sheet fi brillizing 
peptides are resistant to proteolysis, degradation, and turnover 
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in biological environments. As an alternative to the incorpora-
tion of enzyme cleavage sites to increase matrix biodegrada-
bility, Collier and co-workers have designed self-assembling 
depsipeptides by substituting amino acids in the Q11 peptide 
with their corresponding α-hydroxy acid analogs. [ 116 ] Replacing 
the amide bond with ester bonds in the peptide backbone 
facilitates biodegradation via hydrolysis, enabling the softening 
and eventual clearance of the β-sheet scaffold in vivo following 
tissue regeneration or drug delivery. 
 In addition to self-complementary β-sheet peptides, hydrogel 
scaffolds can be obtained by mixing oppositely charged β-sheet 
peptides. [ 117 ] The electrostatic interactions between the comple-
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 Figure 8.  Q11 fi brillizing peptides bearing cell adhesion ligands form multicomponent co-assembling hydrogels that signifi cantly enhanced endothelial 
cell attachment, spreading and proliferation. A) The modular nature of these peptides enabled multi-factorial experimental designs to evaluate interac-
tions between different ligands and thus formulate a multi-ligand matrix which maximized endothelial cell growth. B) To verify the computational fi nd-
ings, human umbilical vein endothelial cells were cultured on the optimized matrix (opt), a “pre-optimized” formulation representing a combination 
of the best individual ligand concentrations (pre-opt), gels containing only the RGDS ligand (RGDS), optimized gels containing additional YIGSR-Q11 
(opt/YIG), optimized gels containing additional IGSE-Q11 (opt/IGSE), and Q11 gels with adsorbed fi bronectin (FN). Cell growth on the optimized 
matrix was comparable to that on fi bronectin-coated gels, and greater than on the pre-optimized composite gel and gels with individual ligands. C) The 
improved growth rate on the optimized gels could be visualized using microscopy and corresponded to a qualitatively higher expression of endothelial 
marker PECAM-1/CD31 (stained green with DAPI nuclear counterstain). Reproduced with permission. [ 115 ] Copyright 2011, Royal Society of Chemistry.
 Figure 7.  Functionalized peptides with short β-sheet motifs self-assemble into nanofi brous scaffolds that promote cell adhesion, proliferation and 
differentiation. A) RADA16 can be modifi ed with bioactive motifs. As a proof-of concept, a motif from osteogenic growth peptide ALK (ALKRQGRT-
LYGFGG), a cell adhesion motif DGR from osteopontin (DGRGDSVAYG) and an integrin binding motif PRG with two RGD units (PRGDSGYRGDS) were 
appended onto the C-terminus of RADA16 during peptide synthesis. The modifi ed peptides were then mixed with unmodifi ed RADA16 to form composite 
functionalized ALKmx, DGRmx and PRGmx hydrogels. B) Pre-osteoblast MC3T3E1 cells cultured on the pure unmodifi ed RADA16 hydrogels (RAD-1) 
demonstrate low alkaline phosphatase activity, as denoted by the weak bluish staining. Incorporating 1% (w/v) of the modifi ed peptides signifi cant 
increased cell attachment and alkaline phosphatase activity. Because alkaline phosphatase activity correlates with bone formation, the results suggest 
that the incorporation of ALK, DGR and PRG bioactive motifs promote the proliferation and differentiation of osteoblasts. Reproduced from ref.  [ 111b ] .




mentary peptides stabilize the macromolecular structure, 
conferring stimuli-responsive properties. In other words, 
self-assembly, scaffold dissociation and dynamic reassembly 
(self-healing) are stimuli responsive and the mechanical prop-
erties of the hydrogel can be modulated by changes in pH and 
salt concentrations. 
 The self-assembly of charged β-sheet peptides can also be 
triggered by neutralization of the charged residues via judi-
cious pH control. Taking advantage of this property, Hart-
gerink et al. designed a class of ABA multi-domain short pep-
tides where in the B-domain is a neutral β-sheet motif (such 
as hexameric repeats of QL, and SL), fl anked by identical 
A-domains containing charged residues, as exemplifi ed by Ac-
KK(QL) 6 KK-NH 2 , Ac-E(QL) 6 E-NH 2 , Ac-KK(SL) 6 KK-NH 2 , Ac-
E(SL) 6 E-NH 2 . [ 118 ] The use of aliphatic versus aromatic residues 
in the B-domain alters the hydrogen bonding between adjacent 
β-sheets, resulting in changes in nanofi ber morphology and the 
mechanical properties of the bulk hydrogel. [ 119 ] The incorpora-
tion of cysteine into the B-domain in Ac-E(CLSL) 3 E-NH 2 ena-
bled intermolecular disulphide cross-linking, which enhanced 
the stability and mechanical strength of ABA hydrogels. Simi-
larly, ABA peptides containing lysine can be enzymatically 
crosslinked using polyamine oxidase or lysyl oxidase. [ 120 ] The 
modular nature of ABA β-sheet peptide hydrogels accommo-
dates bioactive domains such as RGD cell adhesion motifs 
and matrix metalloprotease-2 cleavage sites. [ 121 ] The resulting 
biofunctional scaffolds demonstrated increased cell viability, 
spreading and encouraged cell migration. These multidomain 
scaffolds can be concurrently loaded with growth factors via 
heparin binding, which promoted vascularization and connec-
tive tissue formation in vivo and can be applied towards regen-
erative endodontics. [ 122 ] Hydrogels loaded with factors secreted 
by stem cells have also been successfully shown to revive glo-
merular epithelial cells following diabetes-induced kidney 
injury. [ 112c ] The growth factor release can be further modulated 
by encapsulation into liposomes prior to loading into the pep-
tide hydrogels. [ 123 ] Such composite hydrogels can act as bimodal 
release systems–; therapeutics entrapped in the hydrogel are 
rapidly released while those loaded into liposomes are released 
after a delay, to deliver bioactive moieties at different rates to 
enhance tissue regeneration. 
 Some β-sheet peptides self-assemble into nanofi brous 3D 
scaffolds via intermediate macromolecular structures. A novel 
class of short (7 to 11 amino acids) β-sheet peptides developed 
by Aggeli and co-workers assemble in an anti-parallel fashion 
via hydrogen bonding to form nanotapes that are a single-
molecule thick. [ 124 ] Pairs of nanotapes subsequently stack to 
form ribbons which are stabilized by π–π interactions of the 
aromatic residues in the motif. Further aggregation of peptide 
ribbons into fi brils which in turn condense to form 3D fi ber 
networks that entrap water. The physical properties, surface 
chemistry and stimuli responsiveness of the resulting peptide 
hydrogels can be modulated by subtle changes in amino acid 
sequence. [ 125 ] Binary systems with oppositely charged comple-
mentary peptides have also been designed. [ 126 ] The 11-mer pep-
tide P 11–4 (Ac-QQRFEWEFEQQ-NH 2 ) has been applied as an 
injectable scaffold for treating bone defects, dental hypersensi-
tivity and dental decay. [ 127 ] The self-assembling peptide scaffold 
induces de novo nucleation of hydroxyapatite, increases enamel 
remineralization and retards demineralization. [ 128 ] Recent 
clinical safety trials with a single application of P 11–4 to dental 
lesions demonstrated safety in human patients and concomi-
tant enamel regeneration within 30 days. [ 129 ] 
 Loop-and-strand sequences that occur in natural beta-
structured fi brous proteins can also be exploited towards the 
design of short, self-assembling peptides. Such an octapeptide, 
NSGAITIG from the fi brous shaft of the adenovirus fi ber pro-
tein self-assembles into amyloid-type fi brils. [ 130 ] The residues 
NSG belong to a loop and the rest of the sequence to a strand 
within the native protein structure. In the assembled fi bril 
context, the residues N and S do not belong to the self-assem-
bling core but remain accessible and prone to modifi cation. [ 131 ] 
Binding of inorganic materials such as metal nanoparticles [ 132 ] 
and silica [ 133 ] could be promoted through punctual amino acid 
changes at these positions without affecting assembly. When 
aspartates were introduced at these positions, the deposition of 
calcium phosphates was promoted on the fi brils. Furthermore, 
when immobilized on 3D laser-fabricated scaffolds, the miner-
alized fi brils strongly supported attachment and proliferation of 
a preosteoblastic cell line and exhibited a statistically signifi cant 
increase of biomineralization. [ 134 ] 
 The introduction of an artifi cial tetrapeptide β-turn ( D VPPT) 
containing of a single D-amino acid, to join two β-sheets 
creates a β-hairpin conformation. Through rational design, 
Pochan, Schneider and colleagues developed a series of 
β-hairpin scaffolds. [ 135 ] During self-assembly, these peptides 
fold into β-hairpins in response to changes in light, [ 136 ] pH, [ 137 ] 
ion concentration, [ 138 ] and temperature. [ 135b ] The β-hairpins 
pack in an orderly fashion along their hydrophobic faces to 
form bilayers. The bilayers further aggregate to form cross-
linked fi brils. The network branching and shear-thinning 
hydrogel properties can be further tuned by careful re-design 
of the fl anking β-sheets to optimize the packing of adjacent 
β-hairpins. [ 139 ] These peptides also exhibit tuneable, stimuli-
responsive re-gelation kinetics following mechanical disrup-
tion. [ 140 ] This property has been exploited to design injectable 
therapies for tissue regeneration where the shear-thinned 
hydrogel (containing stem cells) can be easily administered to 
the target site for rapid in situ gelation. The introduction of a 
second tetrapeptide β-turn produces a three-stranded β-sheet 
peptide which is also capable of self-assembly into nanofi brous 
hydrogels. [ 141 ] Subsequent development of complementary 
peptide hydrogels was inspired by classical domain swapping 
mechanisms that trigger protein fi brillogenesis. [ 142 ] β-hairpin 
hydrogels have been used for sustained release of encapsu-
lated proteins, wherein the release kinetics is infl uenced by 
the hydrophobicity, charge and molecular weight of the bio-
molecules. [ 143 ] To enhance cell proliferation and infl uence cell 
behavior, cell signaling motifs such as MLPHHGA have be 
appended to direct hydroxyapatite mineralization for dental 
tissue regeneration [ 144 ] ( Figure  9 ). On a side note, several 
β-hairpin peptides demonstrated inherent antibacterial activity 
without causing concurrent hemolysis. [ 145 ] Further optimiza-
tion to incorporate more arginines into the fl anking β-sheets 
increased their effi ciency in killing gram-positive and gram-
negative bacteria, including multi-drug resistant strains. [ 146 ] 
Such peptides are of interest as injectable scaffolds for wound 
healing. 
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 β-sheet self-assembling motifs gives rise to stable, biomi-
metic nanofi brous hydrogels. Exploiting the strong forces that 
govern β-sheet self-assembly, biofunctional domains can be 
conjugated to the self-assembling domain without affecting the 
bulk structural properties. This has enabled scientists to modu-
late the stability of the scaffold (through incorporation of enzy-
matic degradation sites), display bioactive epitopes (through 
the attachment of cell adhesion and cell signaling ligands) and 
release soluble biochemical cues to infl uence cell behaviour. 
The various molecular domains can be changed independently, 
further increasing the complexity of the resulting scaffold and 
enhancing their potential to mimic native ECM to optimize 
tissue regeneration. 
 3.2.  Short Peptides with α-Helical Secondary Structure 
 Self-assembling α-helical motifs are typically based on heptad 
(7 residues) repeats which dictate the intra- and intermolec-
ular peptidic interactions. During self-assembly, two or more 
α-helical strands oligomerize to form coiled-coil structures that 
further elongate and aggregate into nanofi brous scaffolds. 
 Taking inspiration from leucine-zipper motifs, Woolfson 
and colleagues rationally designed a series of two-component 
α-helical peptides that self-assemble into hydrogelating self-
assembling fi bers (hSAFs). [ 147 ] Two peptides, each consisting 
of four heptad repeats, form heterodimer fi brils upon mixing 
at physiological conditions ( Figure  10 ). The fi bril is stabilized 
by an interhelical hydrophobic core of aliphatic residues at the 
fi rst and fourth position of the heptad, and further stabilization 
is provided by asparagine pairing at specifi c locations. Charged 
residues at the fi fth and seventh positions of the heptad enable 
electrostatic interactions which result in the staggered forma-
tion of “sticky ends” for facile lengthwise extension; while polar 
residues at the second, third and sixth position enable fi bril 
aggregation into mature fi bers and thus determine fi ber thick-
ness and fl exibility. Branched fi brils can be obtained by intro-
ducing a third “blunt end” helical peptide. [ 148 ] Biotin and short 
peptide “tags” can also be introduced as branches into linear 
hSAFs by appending to lysine residues within the heptad [ 149 ] 
or the N-terminus during synthesis. [ 150 ] This would allow for 
scaffold functionalization post-assembly to introduce bioactive 
motifs conjugated to streptavidin or antibodies. However, this 
approach is highly ineffi cient as the incorporation of tags often 
interferes with heterodimer formation, resulting in the fi bril 
destabilization. To circumvent this, specifi c residues in the 
sixth position of the heptad can be substituted with synthetic 
amino acids bearing azido and allyl moieties, without compro-
mising their propensity to self-assemble. [ 151 ] Post-assembly, cell 
adhesion ligands such as RGDS can be appended by copper(I)-
catalyzed azide-alkyne and thiol-ene click reactions. [ 152 ] Such 
bioorthogonal dual functionalization will enables the pres-
entation of two different ligands independently to infl uence 
cell fate. While undecorated hSAF hydrogels support support 
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 Figure 9.  Cell signaling motifs, such as MLPHHGA (MDG), can be appended to MAX8 β-hairpin hydrogels to direct hydroxyapatite mineralization 
for dental tissue regeneration. A) The resulting peptide, MDG1 (mineral directing gelator), undergoes triggered folding to form an unsymmetrical 
β-hairpin that self-assembles in the presence of calcium chloride (CaCl 2 ) to yield a mechanically rigid hydrogel. β-glycerophosphate (β-GP) was also 
added to facilitate mineralization. In the presence of alkaline phosphatase (exogenous or secreted by cells), β-GP is hydrolysed and the free phosphate 
reacts with calcium ions to mineralize the matrix. B) Gels entrapping alkaline phosphatase and β-GP sequester calcium phosphate after 24 h, with the 
MDG1 gel accommodating a slightly higher load than the control gels. This demonstrates that the appended C-terminal ligand does not affect gross 
mineralization. C) However, the ligand infl uences the crystal morphology. Transmission electron microscopy analysis further demonstrates distinct 
differences in the crystallinity of the deposited minerals within each of the peptide hydrogels. Mineral deposited within the MDG1 gel was highly crys-
talline and elongated, resembling biological apatite, while few and no particles were observed on the cMDG1 and MAX8 gels respectively. Reproduced 
with permission. [ 144 ] Copyright 2010, Elsevier.




neuronal cell growth and neurite extension, [ 147a ] scaffolds func-
tionalized with RGDS demonstrated greater cell adhesion, pro-
liferation and differentiation of precursor cells. [ 152 ] 
 Trimeric α-helical peptides that self-assemble into syn-
thetic collagen scaffolds are of great interest as scaffolds for 
tissue engineering. Collagen is a major structural component 
of the ECM and is able to support cell attachment and prolif-
eration which has led to its widespread utilization in cell and 
tissue scaffolds. However, as collagens are typically extracted 
from animal sources, concerns regarding contaminations by 
pathogens, batch-to-batch variability, and immunogenicity 
have largely curtailed their clinical applications. To circumvent 
these issues, scientists have synthesized collagen-mimetic pep-
tides (CMP) based on X-Y-glycine motifs from natural collagen 
sequences. Stable triple helical structures have been obtained 
using homotrimeric [ 153 ] and heterotrimeric [ 154 ] motifs. How-
ever, these systems formed bulk amorphous aggregates rather 
than nanofi bers. To facilitate fi ber assembly, various strategies 
were evaluated, including the re-design of the α-helical building 
blocks to generate sticky ends, [ 155 ] the incorporation of hydro-
phobic residues at the periphery to facilitate aggregation, [ 156 ] 
the inclusion of cysteine residues to form cysteine knots, [ 157 ] 
and the conjugation of metal-binding ligands at the termini for 
metal-triggered fi bril assembly. [ 158 ] Chmielewski and colleagues 
successfully cultured human endothelial cells on nanofi brous 
hydrogels prepared from metal-triggered self-assembling 
CMPs. [ 158b ] These scaffolds can also be functionalised with 
N-terminal cell adhesion motifs and His-tagged growth fac-
tors to encourage cell proliferation. [ 159 ] More recently, Kumar 
et al demonstrated that their sticky ended homotrimeric KOD 
CMPs formed hydrogels thatpromote hemostasis; platelets 
adhere to these hydrogels and become activated, resulting in 
the formation of blood clots. [ 160 ] CMPs have also been exploited 
for functionalizing polymeric scaffolds. [ 161 ] The innate ability of 
CMPs to associate with collagen fi bers via strand invasion was 
exploited for immobilizing therapeutics to tissues to facilitate 
regeneration and for spatial photo-patterning of scaffolds to 
create complex tissue constructs. [ 162 ] 
 A unique class of ultrashort aliphatic peptides with 
sequences from 3-mers to 7-mers self-assemble into nanofi -
brous hydrogels via α-helical intermediates. [ 163 ] The unique-
ness of this peptide class is based on their unusual behavior to 
go through structural transitions from random coil to helical 
intermediates before they reach their fi nal β-turn structure. 
Therefore, the peptides are able to adopt various secondary 
structures, depending on their respective stage in the assembly 
process. The 3-mer peptides are the shortest aliphatic peptides 
reported to self-assemble into fi brous hydrogel scaffolds. In 
marked contrast to the α-helical peptides previously described, 
these peptides do not conform to the heptad structure, and in 
fact belie the general view that α-helical structures can only be 
observed in peptide sequences with at least 7 amino acids (cor-
responding to one complete turn of the helix). Consisting of 
three to seven aliphatic amino acids, the characteristic sequence 
motif consists of an acetylated N-terminus aliphatic tail of 
hydrophobic amino acids capped by a polar C-terminal residue 
( Figure  11 ). During self-assembly in aqueous conditions, the 
amphiphilic peptides form parallel-antiparallel α-helical pairs 
Adv. Healthcare Mater. 2015, 4, 2557–2586
www.advhealthmat.de
www.MaterialsViews.com
 Figure 10.  Functionalized short peptides with α-helical motifs self-assemble into hydrogels which promote cell growth and tissue regeneration. 
A) Coiled-coil heptad α-helical hSAF peptides form staggered parallel heterodimer fi brils which further aggregate into 3D nanofi brous hydrogels. 
Adapted with pemission from  [ 152 ] . B) Helical wheel representation of the peptides. C) These hydrogels promote the growth and differentiation of rat 
adrenal pheochromocytoma (PC12) cells in vitro, as observed by neurite extension the presence of nerve growth factor. D) After a lag of 4 days, PC12 
cells cultured on hSAF hydrogels (fi lled circles) developed neurites, which subsequently elongated over time. Cells cultured on Matrigel (open squares) 
were used as a positive control. Panels B, C, and D reproduced with permission. [ 147a ] Copyright 2009, Nature Publishing Group.





which subsequently stack into β-turn fi brils. Aggregation of 
fi brils gives rise to nanofi brous 3D networks that support cell 
growth for in vitro and in vivo biomedical applications. [ 164 ] 
Most notably, the hydrogels enhanced epithelial regeneration 
and wound closure when applied as burn wound dressings. [ 165 ] 
Monodispersed silver nanoparticles that were released from 
ultrashort peptide hydrogels effectively killed gram-positive and 
gram-negative bacteria. This offers additional possibilities for 
the wound care, when using peptide hydrogels. Their physical 
properties, particularly their high and tunable mechanical stiff-
ness, also make them attractive candidates for orthopedic appli-
cations. [ 164 ] The rigidity and stability can be further increased 
by crosslinking. Peptide candidates with C-terminal cysteines 
are amenable towards oxidative crosslinking via the formation 
of intermolecular disulphide bonds. [ 166 ] Biofunctional motifs 
can be similarly appended to enhance cell adhesion and infl u-
ence cell behavior. Biofunctionalization can also be achieved 
by incorporating alkyne groups (to the peptide N-terminus) for 
click chemistry. [ 167 ] 
 In view of the ordered pattern of molecular interactions 
in α-helical self-assembling systems, changes to the peptide 
sequence modulates the macromolecular architecture and 
physiochemical properties of the resulting hydrogel scaffolds. 
However, signifi cant care must be taken during bio-function-
alization as large motifs conjugated to the peptidic building 
blocks can potentially de-stabilize the bulk hydrogel structure. 
Post-assembly modifi cations are thus favored, wherein bioac-
tive moieties are attached to the assembled scaffold via click 
chemistry or strand invasion. These recent advances in func-
tionalization have led to the development of better synthetic cell 
culture substrates, as well as bioactive scaffolds that promote 
cell proliferation, migration and differentiation for regenerative 
medicine. 
 3.3.  Short Peptides with Aromatic Residues and Chemical 
Functional Groups 
 The shortest known aromatic peptides which form fi brous 
hydrogels are dipeptides with aromatic residues. The aro-
matic side chains are assumed to participate in π–π stacking 
and contribute to the overall hydrophobic interactions that 
drive assembly into fi brillar scaffolds. The dipeptide IF is 
the shortest natural sequence known to form fi brillar net-
works, [ 168 ] though very high concentrations (exceeding 
150mg/mL) of peptide are needed for hydrogelation. The 
incorporation of additional aromatic residues facilitates self-
assembly. Dipeptides of phenylalanyl-dehydrophenylalanine 
(F-ΔF) forms stimuli-responsive hydrogels which have been 
applied as tunable, self-regulated drug delivery platforms for 
the sustained release of vitamins, antibiotics and drugs. [ 169 ] 
These hydrogels can be covalently functionalized with cell 
adhesion motifs (such as RGD) to support cell adhesion and 
proliferation [ 170 ] ( Figure  12 ). The propensity for dipeptide 
self-assembly into nanofi brillar hydrogels can be enhanced 
by N-terminus capping with aromatic functional groups, as 
exemplifi ed by fl uorenylmethoxycarbonyl-capped dipheny-
lalanine (Fmoc-FF). [ 171 ] Other N-terminal caps which also 
facilitate self-assembly include naphthalene and carboxy-
benzyl. [ 172 ] These hydrogels can be functionalized by the 
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 Figure 11.  A class of ultrashort amphiphilic peptides are unique in that they α-helical intermediates despite having less than 7 amino acids. A) This 
secondary structure is attributed to antiparallel pairing of peptide monomers. Subsequent stacking and aggregation gives rise to fi brils which in turn 
condense to form nanofi bers which entrap water to form hydrogels. Reproduced with permission. [ 163 ] B) These hydrogels support the 3D culture of 
encapsulated human adult mesenchymal and embryonic stem cells. Human mesenchymal stem cells (hMSC) elongated when cultured on the nanofi -
brous scaffolds, as refl ected by cytoskeletal actin staining (in green, with blue DAPI nuclear counterstain). Reproduced with permission [ 233 ] copyright 
2015, American Chemical Society. Human embryonic stem cells (hESC) grow as colonies which maintain their pluripotency, as shown by immuno-
histochemical staining for Oct4 (green) and Nanog (red) transcription factors. C) The hydrogels can also be applied as wound dressings for partial 
thickness burns, wherein they accelerate skin regeneration. Reproduced with permission. [ 165 ] Copyright 2014, Elsevier.




conjugation of motifs (such as glycosylation [ 173 ] and cell adhe-
sion sequences [ 174 ] ) pre-assembly. Functionalization can also 
be achieved by mixing Fmoc-protected peptide motifs (such 
as Fmoc-RGD) with Fmoc-FF. Such hydrogels support the 
growth of primary cells, notably chondrocytes [ 175 ] and fi bro-
blasts (which remodeled the matrix by secreting ECM) [ 176,177 ] 
and are thus of interest as scaffolds for organotypic tissue cul-
ture (Figure  12 ). 
 Peptide self-assembly is an elegant and expedient bottom-up 
approach towards designing 3D biological scaffolds, in view of 
their nanofi brillar structure, biocompatibility, biodegradability, 
ease of synthesis and functionalization. In particular, advances 
in functionalization strategies have led to the development of 
better synthetic cell culture substrates, as well as bioactive scaf-
folds that promote cell proliferation, migration and differentia-
tion for tissue engineering. 
 4.  Self-Assembled Peptide Amphiphiles to Mimic 
Native Extracellular Matrix 
 Self-assembling peptide amphiphiles (PAs) nanofi bers are a 
class of materials that can mimic the essential properties of 
native ECM including viscoelastic properties, nanofi brous 
topography and bioactive signaling. The β-sheet forming PA 
molecules can self-assemble into 1D nanostructures, predomi-
nantly nanofi bers with a cylindrical geometry, through inter-
molecular hydrogen bonding. Under physiological conditions, 
these 1D nanofi bers can form 3D hydrogel networks imitating 
the highly hydrated nanofi brous structure of native ECM. In 
addition, easy tunability of bioactivity by simply altering the 
amino acid sequences, allows construction of biomaterial plat-
forms mimicking the specifi c functions of the ECM to direct 
desired cellular outcome for medical applications. Here, we 
highlight the molecular self-assembly mechanisms of PA mol-
ecules as well as the biophysical and biochemical cues at the 
interface of self-assembled peptide nanofi bers with biological 
systems. 
 4.1.  Supramolecular Structure and Self-Assembly Mechanisms 
 Nanofi ber forming single tail peptide amphiphiles are a class 
of self-assembling building blocks to construct nanoscale 
engineered materials for biomedical applications with their 
inherent biocompatibility and biodegradability. [ 178 ] A peptide 
amphiphile can be considered as a hybrid molecule containing 
a hydrophobic alkyl tail with a variable length and a relatively 
hydrophilic peptide sequence attached to this hydrophobic 
chain. [ 179 ] The hydrophilic peptide sequence, which is adjacent 
to the hydrophobic alkyl group, can be composed of three key 
structural regions ( Figure  13 A). [ 180 ] The fi rst segment of the 
hydrophilic region that drives the nanofi brous assembly of 
PA molecules is the β-sheet forming peptide sequence, which 
consists of hydrophobic amino acids promoting the intermo-
lecular hydrogen bonding. As a second segment, a charged 
peptide sequence containing acidic or basic amino acids can 
be attached to the β-sheet forming segment to enhance the 
solubility of PA molecules and to trigger self-assembly and 
gelation through pH changes or addition of counter ions. 
Finally, the N-terminus of the PA molecule and the third seg-
ment of the hydrophilic region can contain bioactive signaling 
epitopes with specifi c amino acid sequences that are derived 
from native ECM proteins to provide cell-material interac-
tions. These specifi c bioactive epitopes can interact with cell 
surface receptors in a similar manner to native ECM proteins 
to mediate cellular responses by initiating specifi c signaling 
pathways within cells. 
 Self-assembly of PA molecules in aqueous environments 
depends on multiple driving forces. Three main energy con-
tributions including hydrophobic collapse of the alkyl groups 
guided by entropic and enthalpic effects, hydrogen bonding and 
side chain interactions, and electrostatic interactions between 
the charged amino acids, determine the self-assembly into fi nal 
nanostructures. Self-assembly occurs as a result of the driving 
force between alkyl chains to aggregate in aqueous environ-
ment which leads the formation of micellar nanostructures. [ 181 ] 
Due to the hydrophobic packing, alkyl groups constitute 
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 Figure 12.  Short Fmoc-protected dipeptide scaffolds can be functionalized by mixing with Fmoc-protected ligands such as cell adhesion (RGD) motifs. 
A) The proposed supramolecular model suggests that the functionalized peptide self-assembles into 3 nm fi brils and further assembles laterally into 
larger ribbons with RGD sequences presented on the fi ber surface. B) The functionalized peptides can be mixed with unmodifi ed peptides to form func-
tionalized hydrogels. The degree of functionalization can be controlled by varying the concentration of Fmoc-RGD peptides added. The functionalized 
Fmoc-FF/RGD hydrogels enabled fi broblast cell adhesion, with maximal cell spreading achieved when the composition of RGD-functionalized peptide 
exceeded 30% (M/M). The insert refl ects the attachment and spreading of the cultured fi broblasts after 48 h (stained with calcein in green). The cells 
also secrete extracellular matrix proteins to “remodel” the scaffold. Reproduced with permission. [ 177 ] Copyright 2015, Elsevier.





the inner core of the resulting nanofi bers while the hydro-
philic peptide segments are presented on the fi bers’ surfaces 
(Figure  13 B). A crucial criteria for the self-assembly into nano-
fi bers instead of spherical micelles is the β-sheet formation 
between the peptide segments. [ 182 ] The β-sheet forming peptide 
region is composed of hydrophobic amino acids that are able to 
form intermolecular hydrogen bonding leading the formation 
of 1D cylindrical nanofi bers. The strength of the intermolecular 
hydrogen bonding determines the self-assembly kinetics of the 
amphiphilic system. Spherical micelles with random β-sheets 
can form a weak hydrogen bonding system while the increased 
hydrogen bonding can break the spherical organization to form 
the cylindrical nanofi bers with β-sheets coordinated along the 
long axis. [ 183 ] 
 Charged amino acids also assist the self-assembly since 
they are relatively weak acids or bases. A certain number of 
charged amino acids should be suffi cient to provide solubility 
and to assist with purifi cation. [ 184 ] The presence of impuri-
ties and multivalent ions might change the range of elec-
trostatic interactions in an aqueous environment, and as a 
result, self-assembly of the PA molecules can be affected from 
the environmental factors as well. Net electrostatic effect of 
a charge carrier in solutions is measured by Debye length. 
Low ionic strength and electrostatic repulsion between the 
charged residues result in long Debye length limiting the self-
assembly into 1D nanofi bers. [ 185 ] Self-assembly can be trig-
gered by adjusting the pH to acidic or basic values or by using 
screening electrolytes depending on the charge selection to 
shorten the Debye length. [ 179 ] This pH or ion-responsive fea-
ture of PA molecules provides an injectable encapsulation 
platform which can be used for the delivery of bioactive mole-
cules (i.e., proteins, growth factors, cells, etc.) with minimum 
invasion. [ 183 ] Upon injection, self-assembly into nanofi bers 
and gelation can be immediately triggered by the presence 
of electrolytes in the physiological environment. In addition, 
oppositely charged PA molecules can be mixed at certain volu-
metric ratios to induce self-assembly through charge neutrali-
zation. [ 186 ] Under physiological conditions, oppositely charged 
PA molecules bearing various biological epitopes can self-
assemble into nanofi bers presenting multiplex bioactive sig-
nals in a high amount at their surfaces. By combining the co-
assembly strategy with the bioactive signaling epitopes, which 
constitute the last element of hydrophilic peptide segment, it 
can be possible to obtain functional hydrogels which present 
multiple bioactive signals in a synergistic way to regulate cel-
lular functions. 
 4.2.  Presentation of Bioactive Signals 
 To mimic the signaling role of the native ECM, many polymeric 
materials modifi ed with well-known bioactive signal sequences 
have been introduced. However, beyond all of the available 
polymeric material platforms, PA molecules offer the most 
convenient building blocks through easy modifi cation of their 
bioactivity by simply changing the amino acid sequences. 
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 Figure 13.  Molecular structure of a peptide amphiphile (IKVAV-PA) molecule. A-1) hydrophobic alkyl tail, A-2) β-sheet forming segment, A-3) charged 
amino acids providing solubility and further gelation, A-4) bioactive epitope. B) Self-assembly of PA molecules into nanofi bers. C) Transmission electron 
microscope (TEM) image of PA nanofi bers. D) SEM image of PA gel. Reproduced with permission. Copyright 2013, John Wiley and Sons. [ 184 ] 




 The terminal domain of PA molecules has been successfully 
modifi ed with bioactive RGD or RGDS sequence to provide 
enhanced cell attachment. [ 187,188 ] Upon self-assembly, RGDS 
epitopes are presented at the surfaces of 1D cylindrical nano-
fi bers similar to the fi brous nanoarchitecture of native ECM. 
It has been demonstrated that RGDS modifi ed PA (RGDS-
PA) systems successfully facilitate adhesion, spreading and 
migration of different cell types including fi broblasts, [ 189 ] bone 
marrow mononuclear cells (BMNCs) [ 190 ] and breast cancer 
cells. [ 191 ] In addition to fi bronectin, RGD motif is also found in 
the structure of other bone matrix proteins such as bone sialo-
protein and osteopontin. [ 192 ] Therefore, RGD bearing PAs not 
only provide the cellular adhesion but also serve as ideal scaf-
folds to induce bone tissue growth and biomineralization. [ 193 ] It 
has been proposed that RGDS-PA can induce osteogenic differ-
entiation of rat mesenchymal stem cells (rMSCs). [ 194 ] RGDS-PA 
was also used for the functionalization of bone implants. NiTi 
implant surfaces supported enhanced adhesion and prolifera-
tion of pre-osteoblastic cells in vitro when they were functional-
ized with RGDS-PA. [ 195 ] In addition, it has been demonstrated 
that RGDS-PA is also effective for enamel regeneration. [ 196 ] 
When used as a scaffold for enamel organ epithelial (EOE) cells, 
RGDS presenting PA nanofi bers induced enamel regeneration 
and expression of amelogenin and ameloblastin proteins which 
take part in natural enamel formation process. 
 Human corneal keratocytes (HTK) cultured on laminin-
mimetic PA nanofi bers modifi ed with YIGSR peptide sequence 
(YIGSR-PA) retained their characteristic morphology and 
showed enhanced proliferation when compared to fi bronectin-
mimetic RGD-PA nanofi bers. [ 197 ] In addition, YIGSR-PA hydro-
gels increased keratocyte migration to the injured site and sup-
ported stroma regeneration when they were used in vivo for 
damaged rabbit corneas. [ 197 ] 
 There are also other short peptide sequences derived from 
native collagen, which is an important structural component 
of bone ECM, such as DGEA and GFOGER. Both DGEA and 
GFOGER peptide sequences are known to bind integrin α 2 β 1 
which is a key transmembrane protein for cell adhesion and 
osteogenesis. [ 198,199 ] However, the number of studies that used 
DGEA and GFOGER conjugated PA nanofi bers remain limited. 
In one example, metal surfaces coated with DGEA-PA were 
found to induce initial adhesion, spreading and early osteogenic 
commitment of human mesenchymal stem cells (hMSCs) 
when compared to non-functionalized surfaces ( Figure  14 ). [ 200 ] 
A similar result showing the osteoinductive effect of DGEA 
containing peptide amphiphiles was also obtained by Anderson 
and co-workers. [ 201 ] DGEA functionalized PAs enhanced the 
alkaline phosphatase activity and osteogenic gene expressions 
of hMSCs. Luo et al. tested the adhesive effect of GFOGER 
functionalized collagen mimetic PAs on HepG2 cells and 
indicated that PA nanofi bers functionalized with GFOGER 
sequence supported the enhanced cell adhesion as well as 
spreading when compared to non-functionalized PA nanofi bers 
and non-amphiphilic GFOGER peptides. [ 199 ] 
 Another adhesive peptide sequence used in the functionali-
zation of PA molecules is KRSR which is found in the struc-
ture of heparin-binding proteins of the native ECM. It has 
been demonstrated that KRSR peptide promotes specifi c adhe-
sion of osteoblasts while attachment of endothelial cells (ECs) 
and fi broblasts is not affected. [ 202 ] Additionally, enhanced oste-
ogenic differentiation of osteoblast-like Saos-2 cells was previ-
ously shown on titanium alloy surfaces coated with the com-
bination of KRSR functionalized PA nanofi bers (KRSR-PA) 
and mussel adhesive protein, 3,4-dihydroxy-L-phenylalanine 
(Dopa), functionalized PA nanofi bers (Dopa-PA). [ 203 ] This 
hybrid application of mussel inspired Dopa-PA with other bio-
active PA nanofi bers also provides a great potential for effi cient 
immobilization of bioactive molecules on metal implant sur-
faces. As a similar approach, PA molecules containing REDV 
peptide sequence (REDV-PA) derived from fi bronectin were 
used together with Dopa-PA to functionalize stainless steel 
stent surfaces. [ 204 ] Combinational approach of Dopa-PA and 
REDV-PA increased the stability of implant coating and selec-
tively promoted endothelial cell adhesion, spreading and pro-
liferation, while those characteristics of smooth muscle cells 
were inhibited ( Figure  15 ). 
 Another bioactive peptide epitope that has been incorpo-
rated to PAs is laminin-derived IKVAV sequence. Previous 
studies have also supported that PA nanofi bers and hydrogels 
functionalized with IKVAV bioactive epitope induce in vitro 
selective differentiation of neural progenitor cells (NPCs) into 
neurons and prevent formation of astrocytes. [ 180 ] One impor-
tant advantage of astrocyte inhibition is that astrocyte differ-
entiation is a reason for scar formation after neural injury. [ 205 ] 
Therefore, IKVAV functionalized PA hydrogels are considered 
as convenient materials for in vivo neural tissue regeneration. 
In one study using mouse spinal cord injury model, injection 
of IKVAV-PA hydrogel to the injury site reduced scar forma-
tion and cell death, induced oligodendroglia formation and also 
improved motor functions of the injured mice. [ 206 ] As a coop-
erative approach, Mammadov et al. combined laminin-mimetic 
IKVAV-PA with a heparan sulfate-mimetic PA decorated with 
carboxylic acid, hydroxyl and sulfonate groups. [ 207 ] Combina-
tion of these two bioactive components imitates the interac-
tion of laminin with heparan sulfate proteoglycan (HSPG) 
similar to neural ECM. [ 208 ] Hybrid PA system promoted the 
neurite outgrowth of PC-12 cells and prevented the inhibitory 
effect of chondroitin sulfate proteoglycans (CSPGs) on neurite 
outgrowth. 
 4.3.  Mechanical Control 
 Cells can sense the mechanical properties of their surrounding 
microenvironment and as a response to mechanical stimuli, 
generated biochemical activity can result in changes in the 
regulation of cellular behavior. [ 209 ] Along with the activation of 
signal transduction cascades, matrix stiffness can direct cellular 
functions such as migration, [ 210 ] proliferation, [ 211 ] and differ-
entiation. [ 212 ] Besides their ability to mimic cellular microen-
vironment with their highly hydrated and porous nature, PA 
hydrogels can serve as a modifi able platform to control the 
mechanical properties of the resulting hydrogel systems to 
orientate cell-material interactions and to direct cellular func-
tions by altering the material stiffness. Various strategies, 
which include either non-covalent or covalent methods, have 
been implemented to modify the mechanical properties of PA 
hydrogels. 
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 One possible non-covalent method for controlling the vis-
coelastic properties of resulting gel systems is to direct self-
assembly through altering the hydrogen bonding capacity of 
PA molecules by changing the internal peptide sequence. PA 
molecules were previously designed with different hydrogen 
bonding domains by changing the number and sequence of 
valine and alanine amino acids in the β-sheet segment. [ 213 ] The 
ordering of the β-sheets had a pronounced effect on gel stiff-
ness. Increased number of valine residues and decreased dis-
tance of the valine segment to the hydrophobic core resulted 
in formation of aligned hydrogen bonds along the fi ber axis 
and enhanced mechanical stiffness of the resulting hydrogels. 
On the other hand, increased number of alanines and the 
presence of sequences promoting twisted β-sheets supported 
the formation of soft hydrogels by weakening the peripheral 
hydrogen bonds. Therefore, designing strategies based on the 
modifi cation of molecular packing can provide control over the 
bulk mechanical properties of the PA hydrogels. Mechanical 
properties of PA hydrogels can also be altered by the pres-
ence of counter ions providing dynamic crosslinking through 
electrostatic screening of charged residues. The effect of mul-
tivalent ions were investigated on the bulk viscoelastic prop-
erties of PA hydrogels. [ 118 ] When negatively charged PA mole-
cules were self-assembled by addition of Mg +2 , non-covalent 
crosslinking resulted in increased storage modulus of PA 
hydrogels by up to 10 fold. They also demonstrated a cova-
lent crosslinking strategy via addition of cysteine residues to 
the peptide sequence. Under oxidizing conditions, formation 
of disulfi de bonds between cysteine residues provided the 
covalent capture of nanofi bers into a high molecular weight 
polymer network with 60 fold increased mechanical stiffness. 
As a similar approach, Ca 2+ ions were used for gelation and 
controlled the bulk mechanical properties through inter-fi ber 
crosslinking. [ 214 ] The electrostatic screening through divalent 
or trivalent counterions resulted in mechanically more strong 
hydrogels by providing intermolecular and interfi ber ionic 
crosslinking, while screening through monovalent ions does 
not. In addition, even the ions with same valence resulted in 
different mechanical stiffness; d-block divalent ions such as 
Fe 2+ , Cu 2+ , Zn 2+ produced stronger hydrogels when compared 
to s-block divalent ions such as Ca 2+ , Mg 2+ , and Ba 2+ . [ 214,215 ] 
A reversible crosslinking method was developed with inspi-
ration from mussel adhesive protein (Dopa) to improve the 
mechanical properties of self-assembled PA networks without 
damaging the intrinsic self-healing properties of the supramo-
lecular system ( Figure  16 ). [ 216 ] Conjugation of Dopa residue to 
PA molecules provided pH dependent dynamic crosslinking of 
PA molecules to form tris Fe(Dopa) 3 groups in the presence of 
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 Figure 14.  Early stage interactions of hMSCs with the osteoinductive nanofi bers. A) Adhesion and spreading of hMSCs on the nanofi ber coatings in 
serum-free medium at 2 h 15 min. B) Confocal images of DMP-1 immunostaining. The arrows point the nuclear, cytoplasmic, or extracellular localiza-
tion of DMP-1. Green shows DMP-1, gray shows fi lamentous actin, red shows the nucleus. Localization of DMP-1 protein inside the cell is informative 
about the differentiation stage of the cell within the osteoblast linage. On DGEA-PA containing PA combinations, more than 60% of the cells showed 
predominant nuclear localization, showing that more than half of the cells differentiated on these nanofi bers were at the preosteoblast stage. Repro-
duced with permission. [ 200 ] Copyright 2014, American Chemical Society.




iron ions. Strikingly, the storage modulus of iron-crosslinked 
Dopa conjugated PAs (DopaK-Pa) was similar to the cova-
lently crosslinked DopaK-PA and the system retained its pH 
dependent reversibility and self-healing properties as in the 
case of uncrosslinked supramolecular network. 
 4.4.  Hierarchical Assemblies of Peptide Amphiphiles 
 As mentioned above, in order to induce the complex biological 
functions such as tissue regeneration, supramolecular systems 
should exhibit high order assemblies at the similar length scale. 
To mimic the high order organization of natural tissues, a lim-
ited number of hierarchical supramolecular PA assemblies 
have been introduced. 
 One of the most recent examples has been introduced by 
Capito and co-workers. [ 217 ] By taking advantage of diffusion bar-
rier at the liquid-liquid interface, hierarchically ordered mem-
branes were developed upon dropping of negatively charged 
hyaluronic acid (HA) solution into positively charged PA solu-
tion ( Figure  17 ). Following the contact of two solutions, PA 
molecules immediately assembled into aligned bundles perpen-
dicular to the diffusion barrier at the interface and produced a 
closed microsac membrane. This hierarchical structure enabled 
permeability to growth factors and proteins, and supported the 
viability of encapsulated hMSCs up to 4 weeks. Additionally, 
upon induction with chondrogenic media, cells differentiated 
into chondrocytes. 
 One common example for the successfully accomplished 
hierarchical organization of PA assemblies is aligned mono-
domain gels bearing a resemblance to long range alignment 
of extracellular fi brils in the heart, brain and spinal cord 
( Figure  18 ). [ 218 ] A basic heat and cool methodology was used 
to induce the production of an aqueous liquid crystal solu-
tion. Dehydration of PA solution via heating followed by 
slow cooling transformed the bundled fi bers into a liquid 
crystalline structure. When this liquid crystalline solution 
is pipetted into calcium chloride solution, the shear force 
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 Figure 15.  A) Design and chemical representation of Dopa-PA, REDV-PA molecules and schematic representation of REDV-PA/Dopa-PA network, 
which was designed to functionalize stainless steel surface to support endothelial cell adhesion, spreading, viability and proliferation. B) Representative 
Calcein AM stained fl uorescent images of HUVECs adhered on the stainless steel surfaces coated with REDV-PA/Dopa-PA nanofi bers, E-PA/Dopa-PA 
nanofi bers and on the bare steel surface at 2 h. Graph showing the relative adhesion of HUVECs and A7r5 smooth muscle cells on REDV-PA/Dopa-
PA and E-PA/Dopa-PA coated surfaces with respect to the bare stainless steel surface at 2 h. *** p < 0.0001, NS: No Signifi cance. Reproduced with 
permission. [ 204 ] Copyright 2011, Elsevier.
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through the pipette promoted hierarchical organization of 
gels into aligned fi bers in macroscale. When cardiomyocytes 
were cultured on these aligned constructs, they proliferated, 
spread along the fi ber axes and spontaneously generated 
electrical potential over the string-like gel structure. The 
same hierarchical organization has been shown to create 
 Figure 17.  A) Schematic representation of the hierarchically ordered sac formation. B) Open and C) closed sac formed by injection of a fl uorescently 
tagged hyaluronic acid (HA) solution into the PA solution. D) Self-assembled sacs with different sizes. E) Scanning electron microscopy image showing 
the organization of hierarchically ordered sac membrane: 1) a region with an approximately constant polymer density, 2) a region of parallel fi bers 
where there is a maximum in polymer density, and 3) a region of perpendicular fi bers where the polymer density decays with increasing distance from 
the amorphous region. F) Live/dead image of hMSCs cultured within the sacs showing that most of the cells are viable. Green: live cells, Red: dead 
cells. Reproduced with permission. Copyright 2008, American Association for the Advancement of Science. [ 217 ] 
 Figure 16.  A) Chemical representation of DopaK-PA and K-PA. B) In the presence of iron, tris Fe(Dopa) 3 complexes form dynamic cross-link points. 
C) pH dependent reversibility of the peptide networks. Reproduced with permission. Copyright 2012, John Wiley and Sons. [ 216 ] 
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PA scaffolds mimicking the blood vessels. [ 219 ] A rotating and 
retracting tube was used to align the PA fi bers and calcium 
ions were applied to crosslink the PA fi bers. Smooth muscle 
cells (SMCs) cultured on these artifi cial blood vessels showed 
aligned morphology along the tube axes confi rming that the 
cell behavior can be instructed by hierarchically organized 
materials. 
 Artifi cial matrices of hierarchically assembled PAs can pro-
vide a convenient material platform imitating the complex 
structural organization of natural tissues to provide a proper 
physical environment to direct cell–cell and cell–material 
interactions. 
 4.5.  Dynamic Matrices 
 To properly mimic the dynamic nature of native ECM, devel-
opment of stimuli-responsive materials that are able to change 
their properties upon stimulation are desired. Although some 
dynamic self-assembled systems have been described, the 
number of stimuli responsive supramolecular PA hydrogels 
is still limited. A dynamic PA network was demonstrated with 
an enzyme sensitive peptide sequence, GTAGLIGQ, which has 
specifi c cleavage sites for matrix metalloproteinase-2 (MMP-2) 
( Figure  19 ). [ 220 ] Incorporation of MMP-2 specifi c peptide 
sequence resulted in cell-mediated proteolytic degradation of 
the network and enabled cell migration, spreading and prolif-
eration as well as continuous remodeling of the matrix and fur-
ther ECM production that can support the mechanical integrity 
of the matrix. In addition to promotion of cell motility and inte-
gration, matrix dynamicity is also important for dynamic pres-
entation of bioactive epitopes through the remodeling to control 
cellular processes with time-dependence. In one approach, 
a PA molecule including a photocleavable nitrobenzyl group 
was used to display cell adhesive RGDS peptide in a trig-
gered manner within the matrix. [ 189 ] Fibroblasts attached and 
spread over the surface when RGDS was presented on PA 
nanofi bers, while they showed limited spreading upon irradia-
tion with UV light due to the cleavage of photo-reactive group 
releasing RGDS epitopes to the solution. As a similar photo-
sensitive approach to control the self-assembly process of PAs 
in a dynamic manner, 2-nitrobenzyl group was conjugated to 
the  N -terminal of the PA molecules. [ 221 ] Due to the bulkiness of 
2-nitrobenzyl group near the β-sheet forming segment, photo-
sensitive PA molecules formed a quadruple helix. Upon expo-
sure to UV light at 350 nm, photosensitive bulky groups were 
released and helical structures were dissociated into cylindrical 
single fi brils. 
 Dynamic control of the self-assembly process can also be 
associated with multiple purposes. For example, PA molecule 
 Figure 18.  A,B) A peptide amphiphile solution stained with trypan blue injected into phosphate-buffered saline after heat treatment. C) The same 
solution dragged through a thin layer of aqueous CaCl 2 to form a noodle-like string. D) of aligned nanofi ber bundles in macroscopic strings formed by 
dragging thermally treated amphiphile solutions onto a CaCl 2 solution. E) Calcein-labeled image of cells cultured in string showing the cell alignment 
through the fi ber axes. Reproduced with permission. [ 218 ] Copyright 2010, Macmillan Publishers Ltd.
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containing consensus substrate sequence (RRXSf, X = any res-
idue, f = hydrophobic) specifi c to protein kinase A (PKA) was 
synthesized. [ 222 ] Upon treatment with PKA, serine residues were 
phosphorylated and the nanofi brous structures were disassem-
bled. They used this dynamic self-assembly strategy as a tool for 
targeted drug delivery and the drug loaded PA nanostructures 
were found to be cytotoxic against PKA secreting cancer cell 
lines. 
 These stimuli-responsive re-organizable materials can pro-
vide novel strategies to create multi-functional dynamic mate-
rials to study the effects of matrix modifi cations over time as a 
mimic of natural cell and tissue environment. 
 Figure 19.  A) Schematic illustration of mechanism for cell-responsive nanofi ber network. B) TEM image of nanofi ber network before proteolytic 
degradation and C) after three weeks of incubation with type IV collagenase. D) No spreading was found in non-cell-adhesive network (RDGS) while 
E) elongation and spreading of cells through nanofi ber networks was observed in cell-adhesive network (RGDS). This indicates that the cells produce 
enzymes to remodel the responsive network and track along the adhesive ligands through the network. Reproduced with permission. Copyright 2005, 
John Wiley and Sons. [ 220 ] 
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 5.  Summary and Future Outlook 
 An overview of recent advances in self-assembling proteins, 
peptides, and peptide amphiphiles thatform scaffolds suit-
able for tissue engineering has been presented. In particular, 
special emphasis has been placed on the rational design of 
self-assembling motifs and biofunctionalization strategies to 
enhance cell survival and infl uence cell behavior. 
 The self-assembled scaffold motifs are diverse, ranging from 
minimalistic dipeptides and simplistic ultrashort aliphatic pep-
tides to large “recombinamer” proteins. Alkyl tails or polymers 
can also be conjugated to facilitate self-assembly, forming pep-
tide amphiphiles. The design of the building blocks are by-and-
large inspired by peptidic motifs in fi brous structural proteins 
such as collagen, silks and elastin. Interestingly, motifs derived 
from amyloid-forming proteins are also being explored, by 
virtue of the strong interactions that drive self-assembly and 
the structural rigidity of the resulting scaffolds. More recently, 
advances in chemistry to enable the synthesis and incorpora-
tion of modifi ed amino acids and peptidomimetics have driven 
the concomitant emergence of de novo self-assembling motifs. 
These motifs are often composed of unique secondary struc-
tures that are not found in nature. Along with greater under-
standing of the intra- and intermolecular forces that drive self-
assembly, computational tools are increasingly being used to 
optimize the rational design of self-assembling motifs, model 
their interactions and predict their bulk properties. This has 
signifi cantly broadened the variety of self-assembling peptidic 
motifs. 
 The complexity of self-assembled scaffolds is further 
increased by the modular nature of many building blocks. 
The bulk properties of the scaffold can be tuned by com-
bining blocks with different structural and mechanical prop-
erties. Cross-seeding between natural and designer building 
blocks is also possible, as exemplifi ed by the recombinant 
protein [(AEAEAKAK) 2 -AG(GPGQQ) 6 -GS] 9 -(AEAEAKAK)2-
AG(GPGQQ). [ 223 ] By replacing the alanine stretches in spider 
silks with the amphiphilic β-sheet self-assembling motif 
(AEAEAKAK) 2 , [ 224 ] the resulting “recombinamer” self-assem-
bled into a membrane consisting of beta-structured fi brils 
embedded in a less structured matrix which preserves the beta-
turn forming propensity of the GPGQQ domain for imparting 
elasticity. [ 223 ] Given the myriad modular domains available, 
there are open-ended possibilities for the design of modular 
structural scaffolds. 
 Increasingly, non-structural modules are being appended 
to self-assembling scaffolds to confer biological functionality. 
Most notably, short cell-adhesion sequences of three to fi ve 
residues are often conjugated to the self-assembling module 
as a proof-of-concept to demonstrate the ease of function-
alization and to enhance biocompatibility. With the develop-
ment of phage-display screening techniques, an increasing 
number of novel short biofunctional peptide candidates have 
been identifi ed as promising ligands to fulfi ll specifi c appli-
cations in stem cell differentiation and immune modulation. 
Due to their length, short peptides do not typically hinder 
self-assembly, and can be easily added during peptide syn-
thesis or post-assembly. Longer sequences such as the 19-mer 
silica-nucleating peptide R5 have also been successfully 
incorporated. Care has to be taken so that the appended 
sequences do not impede self-assembly, and remain accessible 
on the structural framework post-assembly. The latter is typi-
cally achieved via the insertion of fl exible spacer sequences, 
especially in the recombinant protein context. Recombinant 
proteins offer the additional possibility of incorporating 
longer sequences, including entire protein domains. On the 
other hand, short self-assembling peptides are more amenable 
to computational approaches that can predict appropriate 
positions for incorporation of functional motifs. [ 131,225–227 ] The 
power of these approaches may be applicable to protein scaf-
folds in the near future, as computation design of self-assem-
bling protein nanomaterials can recently be achieved with 
atomic level accuracy. [ 228 ] 
 To pave the way for widespread adoption, the commercial 
large-scale production of GMP-grade peptide and protein mate-
rials should be cost-effective. Most short peptides can be easily 
synthesized using automated solid-phase peptide synthesis at 
gram quantities. Larger “recombinamer” proteins are prepared 
using recombinant production approaches. Recent develop-
ments have also led to high production yields of short self-
assembling peptides using recombinant production techniques. 
One such strategy involves fusion to SUMO (small ubiquitin-
related modifi er) protein and subsequent cleavage of the pep-
tide, which was successfully used to prepared variants of P11 
peptides (such as P11–4, Ac-QQRFEWEFEQQ-NH 2 ). [ 229 ] 
 Perhaps one of the bigger challenges that lie ahead is the 
combination of the “bottom-up” self-assembling peptides and 
proteins with the “top-down” processing strategies towards new 
generations of tissue engineering scaffolds. This combines the 
design fl exibility and the control over purity and homogeneity 
that the self-assembling strategies offer with the advantages 
of top-down fabrication, i.e., the possibility to control the scaf-
fold geometry and micro-/nano-topography. Examples include 
electrospinning, [ 230 ] photopatterning, [ 231 ] direct laser writing for 
scaffold fabrication, [ 134,232 ] etc. In the years to come, we expect 
to see rapid and important advances arising from the merger 
of self-assembling technologies with precision processing 
techniques. 
 Note added in proof: While this review was under con-
sideration, the fi rst peptide bioinks for 3D bioprinting were 
reported. [ 233 ] These consist of a subclass of lysine-containing 
hexapeptides that undergo instantaneous gelation within physi-
ological conditions. The resulting biocompatible scaffolds sup-
port long term 3D cultures of encapsulated human stem cells, 
as well as the differentiation of primary cells into organotypic 
skin and gastrointestinal epithelial. 
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